Tag: smart inhalers market insights

  • The Future of theSmart Hospital Market: Growth Trends, Market Size, and Opportunities to Watch

    The Future of theSmart Hospital Market: Growth Trends, Market Size, and Opportunities to Watch

    2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

    Which Primary Drivers Are Supporting the Continued Market Growth of theSmart Inhalers Market?

    The increasing incidence of chronic respiratory diseases (CRDs) is anticipated to propel the smart inhaler market’s expansion. Chronic respiratory diseases (CRDs) include various long-lasting ailments that impact the airways and other lung components. Through monitoring usage and offering reminders for forgotten doses, smart inhalers assist in managing chronic respiratory diseases like asthma and COPD, ensuring regular medication use for symptom relief and outbreak prevention. For example, the National Health Survey conducted by the Australian Bureau of Statistics in 2022 showed that approximately 8.5 million Australians, equivalent to 34% of the population, are afflicted with chronic respiratory diseases. Among these, around 2.8 million people (11%) suffer from asthma, characterized by wheezing and breathlessness due to inflammation of the airways. Furthermore, it is estimated that about 638,000 individuals (2.5%) have chronic obstructive pulmonary disease (COPD), a condition marked by constant airflow restrictions leading to severe breathing problems. Both these diseases pose notable health challenges, interrupting everyday activities and reducing the overall quality of life. Thus, the surge in chronic respiratory diseases (CRDs) is stimulating the growth of the smart inhaler market.

    Get Your Free Sample Report Now – Explore Exclusive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=14196&type=smp

    #How Does the ProjectedSmart Inhalers Market Growth Compare Over the Forecast Period?

    The market size for smart inhalers has experienced significant growth in the recent past. From 2024 to 2025, it is projected to expand from $1.65 billion to $1.81 billion, reflecting a compound annual growth rate (CAGR) of 10.1%. This growth during the historical period can be ascribed to the rise in medical adherence, heightened focus on healthcare centered around the patient, and an escalating demand for integrated healthcare devices.

    In the coming years, the smart inhalers market is anticipated to experience rapid expansion. The market is forecasted to grow to $2.66 billion by 2029, with a compound annual growth rate (CAGR) of 10.1%. The expected growth during the forecast period could be related to the increasing occurrence of chronic respiratory diseases (CRDs), a higher demand for home healthcare, and more widespread use of digital healthcare solutions. Key trends predicted during the forecast period involve the technological progress in smart inhalers, the application of big data analytics, the use of chip-on-sensors, and advancements in sensor technology.

    You can Directly Purchase the Report Here:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14196

    How Are Consumer Market Innovations Shaping the Current and Future Landscape of theSmart Inhalers Market?

    The smart inhaler market is witnessing innovation as major firms strive to develop advanced technologies like digital respiratory health solutions in order to reach a broader clientele, boost sales, and increase income. Digital respiratory health solutions are tech platforms aimed at managing respiratory health issues digitally. For example, in February 2022, US-based pharma service firm, Aptar Pharma, launched HeroTracker Sense, a unique digital respiratory health solution. This particular solution is an add-on device that enhances regular metered-dose inhalers (MDIs) into intelligent connected healthcare devices. It is tailored for global patients struggling with chronic respiratory conditions such as asthma, chronic obstructive pulmonary disease, cystic fibrosis, and COVID-19 related conditions. This new-generation MDI add-on device aims to improve patient life quality. By attaching to an MDI canister, the HeroTracker Sense includes advanced capabilities such as sensors for monitoring inhalation coordination, flow rate, and duration. It provides data via a complementary app, offering medication reminders stamped with date and time, and environment alerts like temperature and humidity. This device is devised to improve patient compliance with prescribed treatments by enabling informed and compliant medication usage.

    Who Are the Key Market Players Influencing the Growth of the Corn and Smart Inhalers Industry?

    Major companies operating in the smart inhalers market are Novartis AG, AstraZeneca Plc, GlaxoSmithKline Plc., 3M Health Care Limited, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Berry Global Group Inc., Aptar Group Inc., Lupin Limited, Findair Sp.Z.o.o., OPKO Health Inc., Nemera France SAS, Vectura Group Limited, Propeller Health, Inspiro Medical Ltd., Biocorp Production, Cohero Health Inc., Pneuma Respiratory Inc., Amiko Digital Health Limited, Cognita Labs LLC, AireHealth Inc., Adherium Ltd., Zeolr Technologies Pvt Ltd., H&T Presspart Manufacturing Ltd.

    Order Your Report Now For A Swift Delivery:

    https://www.thebusinessresearchcompany.com/report/smart-inhalers-global-market-report

    Which Key Market Segments Comprise the Smart Inhalers Market and Drive Its Revenue Growth?

    The smart inhalers market covered in this report is segmented –

    1) By Type: Dry Powdered Inhalers (DPIs), Metered Dose Inhalers (MDIs)

    2) By Indication: Asthma, Chronic Obstructive Pulmonary Disease (COPD), Other Indications

    3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

    4) By End-User: Hospitals, Homecare Settings, Other End-Users

    Subsegments:

    1) By Dry Powdered Inhalers (DPIs): Single-Dose DPIs, Multi-Dose DPIs

    2) By Metered Dose Inhalers (MDIs): Conventional MDIs, Smart MDIs With Connectivity Features

    Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

    https://www.thebusinessresearchcompany.com/customise?id=14196&type=smp

    Which Regions Are Emerging as Leaders in the Smart Inhalers Market?

    North America was the largest region in the smart inhalers market in 2024. The regions covered in the smart inhalers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Browse Through More Reports Similar to the Global Smart Inhalers Market 2025, By The Business Research Company:

    Defibrillator Devices And Equipment Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/defibrillator-devices-and-equipment-global-market-report

    Dental Surgical Devices And Equipment Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/dental-surgical-devices-and-equipment-global-market-report

    Diagnostic And Monitoring Ophthalmic Devices And Equipment Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/diagnostic-and-monitoring-ophthalmic-devices-and-equipment-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Future Outlook of the Smart Inhalers Market: Growth, Trends, and Emerging Opportunities Explored

    Future Outlook of the Smart Inhalers Market: Growth, Trends, and Emerging Opportunities Explored

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What key factors are powering the surge in the smart inhalers market right now?

    The smart inhalers market has seen notable growth, with its size projected to rise from $1.65 billion in 2024 to $1.81 billion in 2025 at a CAGR of 10.1%. Growth in past years was driven by improved medical adherence, increased focus on patient-centric healthcare, and rising demand for connected healthcare devices.

    How fast Is the smart inhalers market expected to grow, and what’s its future value?

    The smart inhalers market is set to expand rapidly, reaching $2.66 billion in 2029 with a CAGR of 10.1%. Growth is driven by the rising prevalence of chronic respiratory diseases, increasing demand for home healthcare, and the adoption of digital healthcare solutions. Key trends include technological advancements, big data analytics, chip-on-sensors, and improvements in sensor technology.

    Get your smart inhalers market report here!

    https://www.thebusinessresearchcompany.com/report/smart-inhalers-global-market-report

    What are the leading drivers of growth in the smart inhalers market?

    The smart inhaler market’s expected expansion is linked to the growing prominence of chronic respiratory diseases (CRDs). This group of long-lasting diseases impacts the lungs’ airways and surrounding structures. Smart inhalers play a crucial role in CRD management by maintaining a record of inhaler use and issuing reminders for those who fail to take their medication, guaranteeing steady medication use for symptom management and prevention of flare-ups. In the 2022 National Health Survey by the Australian Bureau of Statistics, it was reported that around 8.5 million Australians, roughly 34% of the population, live with chronic respiratory conditions. Out of these, around 2.8 million people (11%) are battling asthma, an illness typified by wheezing and shortness of breath stemming from airway inflammation. Around 638,000 individuals (2.5%) are believed to carry chronic obstructive pulmonary disease (COPD), a disease typified by continuous airflow limitation leading to major breathing issues. Both these illnesses create significant health challenges, affecting normal functioning and overall quality of life. Therefore, the escalating prevalence of CRDs is contributing to the upward trajectory of the smart inhaler market.

    What are the key segments defining the smart inhalers market?

    The smart inhalers market covered in this report is segmented –

    1) By Type: Dry Powdered Inhalers (DPIs), Metered Dose Inhalers (MDIs)

    2) By Indication: Asthma, Chronic Obstructive Pulmonary Disease (COPD), Other Indications

    3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

    4) By End-User: Hospitals, Homecare Settings, Other End-Users

    Subsegments:

    1) By Dry Powdered Inhalers (DPIs): Single-Dose DPIs, Multi-Dose DPIs

    2) By Metered Dose Inhalers (MDIs): Conventional MDIs, Smart MDIs With Connectivity Features

    Get your free sample now – explore exclusive market insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=14196&type=smp

    Who are the key players steering the development of the smart inhalers market?

    Major companies operating in the smart inhalers market are Novartis AG, AstraZeneca Plc, GlaxoSmithKline Plc., 3M Health Care Limited, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Berry Global Group Inc., Aptar Group Inc., Lupin Limited, Findair Sp.Z.o.o., OPKO Health Inc., Nemera France SAS, Vectura Group Limited, Propeller Health, Inspiro Medical Ltd., Biocorp Production, Cohero Health Inc., Pneuma Respiratory Inc., Amiko Digital Health Limited, Cognita Labs LLC, AireHealth Inc., Adherium Ltd., Zeolr Technologies Pvt Ltd., H&T Presspart Manufacturing Ltd.

    What emerging trends are influencing the growth of the smart inhalers market?

    Leading businesses in the smart inhaler market are innovating with the creation of sophisticated technologies like digital respiratory health solutions, with the goal of serving a wider consumer base, boosting sales, and increasing profits. Digital respiratory health solutions are technically engineered applications or platforms constructed to tackle and manage lung health conditions digitally. For instance, in February 2022, US-based pharmaceutical services firm, Aptar Pharma, introduced the HeroTracker Sense, a unique digital respiratory health solution and auxiliary connected device developed to convert regular metered-dose inhalers (MDIs) to smart connected health devices. This device, particularly made for globally spread patients battling with persistent respiratory ailments such as asthma, COPD, cystic fibrosis, and conditions related to COVID-19, aims to improve their quality of life. HeroTracker Sense, which attaches to an MDI’s canister, boasts advanced functionalities like sensors that monitor inhalation timing, flow speed, and duration. It provides data through a correlated app, featuring date and time stamps for medication reminders and environmental alerts like temperature and humidity. The device is designed to improve patient compliance to prescribed treatments by promoting well-informed and compliant medication usage.

    Unlock exclusive market insights – purchase your research report now for a swift delivery!

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14196

    Which regions are most influential in expanding the smart inhalers market?

    North America was the largest region in the smart inhalers market in 2024. The regions covered in the smart inhalers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Browse Through More Similar Reports By The Business Research Company:

    Defibrillator Devices And Equipment Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/defibrillator-devices-and-equipment-global-market-report

    Dental Surgical Devices And Equipment Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/dental-surgical-devices-and-equipment-global-market-report

    Diagnostic And Monitoring Ophthalmic Devices And Equipment Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/diagnostic-and-monitoring-ophthalmic-devices-and-equipment-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Growth Opportunities and Trends in the Smart Inhalers Market: Key Insights for 2025-2034

    Growth Opportunities and Trends in the Smart Inhalers Market: Key Insights for 2025-2034

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What is the Projected Compound Annual Growth Rate (CAGR) of the Smart Inhalers Market from 2025 to 2034, and What Factors Influence It?

    In recent times, the size of the smart inhalers market has experienced swift expansion. An increase from $1.65 billion in 2024 to $1.81 billion in 2025 is expected, marking a compound annual growth rate (CAGR) of 10.1%. The strong growth in the past period is due to heightened commitment to medical adherence, an intensified focus on patient-centric healthcare, and a rising demand for connected healthcare devices.

    Predictions for the smart inhaler market size suggest a swift expansion over the upcoming years. It is projected to accrue a value of $2.66 billion by 2029, with a compound annual growth rate (CAGR) of 10.1%. Several factors are set to drive expansion during the forecasted period, including a surge in chronic respiratory diseases (CRDs), an amplified interest in home healthcare, and the wide spread acceptance of digital health solutions. Technological progress in smart inhalers, the application of big data analytics, the implementation of chip-on-sensors, and enhancing sensor technology are major trends expected to shape the market in the forecast period.

    What Key Drivers Are Accelerating the Growth of the Smart Inhalers Market During the Forecast Period?

    The smart inhaler market’s expected expansion is linked to the growing prominence of chronic respiratory diseases (CRDs). This group of long-lasting diseases impacts the lungs’ airways and surrounding structures. Smart inhalers play a crucial role in CRD management by maintaining a record of inhaler use and issuing reminders for those who fail to take their medication, guaranteeing steady medication use for symptom management and prevention of flare-ups. In the 2022 National Health Survey by the Australian Bureau of Statistics, it was reported that around 8.5 million Australians, roughly 34% of the population, live with chronic respiratory conditions. Out of these, around 2.8 million people (11%) are battling asthma, an illness typified by wheezing and shortness of breath stemming from airway inflammation. Around 638,000 individuals (2.5%) are believed to carry chronic obstructive pulmonary disease (COPD), a disease typified by continuous airflow limitation leading to major breathing issues. Both these illnesses create significant health challenges, affecting normal functioning and overall quality of life. Therefore, the escalating prevalence of CRDs is contributing to the upward trajectory of the smart inhaler market.

    Request Your Free Smart Inhalers Market Report Sample Now!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=14196&type=smp

    Who Are the Leading Players Fueling Growth in the Smart Inhalers Market?

    Major companies operating in the smart inhalers market are:

    • Novartis AG_x000D_

    • AstraZeneca Plc_x000D_

    • GlaxoSmithKline Plc._x000D_

    • 3M Health Care Limited_x000D_

    • Boehringer Ingelheim International GmbH_x000D_

    What Are the Emerging Trends Shaping the Future of the Smart Inhalers Market?

    Leading businesses in the smart inhaler market are innovating with the creation of sophisticated technologies like digital respiratory health solutions, with the goal of serving a wider consumer base, boosting sales, and increasing profits. Digital respiratory health solutions are technically engineered applications or platforms constructed to tackle and manage lung health conditions digitally. For instance, in February 2022, US-based pharmaceutical services firm, Aptar Pharma, introduced the HeroTracker Sense, a unique digital respiratory health solution and auxiliary connected device developed to convert regular metered-dose inhalers (MDIs) to smart connected health devices. This device, particularly made for globally spread patients battling with persistent respiratory ailments such as asthma, COPD, cystic fibrosis, and conditions related to COVID-19, aims to improve their quality of life. HeroTracker Sense, which attaches to an MDI’s canister, boasts advanced functionalities like sensors that monitor inhalation timing, flow speed, and duration. It provides data through a correlated app, featuring date and time stamps for medication reminders and environmental alerts like temperature and humidity. The device is designed to improve patient compliance to prescribed treatments by promoting well-informed and compliant medication usage.

    Pre-order Your Report for Quick and Easy Delivery!

    https://www.thebusinessresearchcompany.com/report/smart-inhalers-global-market-report

    What Are the Core Categories and Segments in the Smart Inhalers Market Driving Demand and Growth?

    The smart inhalers market covered in this report is segmented –

    1) By Type: Dry Powdered Inhalers (DPIs), Metered Dose Inhalers (MDIs)

    2) By Indication: Asthma, Chronic Obstructive Pulmonary Disease (COPD), Other Indications

    3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

    4) By End-User: Hospitals, Homecare Settings, Other End-Users

    Subsegments:

    1) By Dry Powdered Inhalers (DPIs): Single-Dose DPIs, Multi-Dose DPIs

    2) By Metered Dose Inhalers (MDIs): Conventional MDIs, Smart MDIs With Connectivity Features

    Which Regions Are Driving Growth in the Smart Inhalers Market?

    North America was the largest region in the smart inhalers market in 2024. The regions covered in the smart inhalers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    What Defines the Scope of the Smart Inhalers Market?

    Smart inhalers refer to medical devices that integrate connectivity with a mobile app, typically via Bluetooth. It is used to enhance the user experience and provide more personalized treatment decisions for individuals with chronic lung conditions such as asthma and chronic obstructive pulmonary disease (COPD).

    Browse Through More Similar Reports By The Business Research Company:

    Defibrillator Devices And Equipment Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/defibrillator-devices-and-equipment-global-market-report

    Dental Surgical Devices And Equipment Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/dental-surgical-devices-and-equipment-global-market-report

    Diagnostic And Monitoring Ophthalmic Devices And Equipment Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/diagnostic-and-monitoring-ophthalmic-devices-and-equipment-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on: